Diagnosis and Management of Acute Ischemic Stroke

Tasneem F. Hasan, Alejandro Rabinstein, Erik H. Middlebrooks, Neil Haranhalli, Scott L. Silliman, James F Meschia, Rabih G. Tawk

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Acute ischemic stroke (AIS) is among the leading causes of death and long-term disability. Intravenous tissue plasminogen activator has been the mainstay of acute therapy. Recently, several prospective randomized trials documented the value of endovascular revascularization in selected patients with large-vessel occlusion within the anterior circulation. This finding has led to a paradigm shift in the management of AIS, including wide adoption of noninvasive neuroimaging to assess vessel patency and tissue viability, with the supplemental and independent use of intravenous tissue plasminogen activator to improve clinical outcomes. In this article, we review the landmark studies on management of AIS and the current position on the diagnosis and management of AIS. The review also highlights the importance of early stabilization and prompt initiation of therapeutic interventions before, during, and after the diagnosis of AIS within and outside of the hospital.

Original languageEnglish (US)
Pages (from-to)523-538
Number of pages16
JournalMayo Clinic Proceedings
Volume93
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Stroke
Tissue Plasminogen Activator
Tissue Survival
Neuroimaging
Cause of Death
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hasan, T. F., Rabinstein, A., Middlebrooks, E. H., Haranhalli, N., Silliman, S. L., Meschia, J. F., & Tawk, R. G. (2018). Diagnosis and Management of Acute Ischemic Stroke. Mayo Clinic Proceedings, 93(4), 523-538. https://doi.org/10.1016/j.mayocp.2018.02.013

Diagnosis and Management of Acute Ischemic Stroke. / Hasan, Tasneem F.; Rabinstein, Alejandro; Middlebrooks, Erik H.; Haranhalli, Neil; Silliman, Scott L.; Meschia, James F; Tawk, Rabih G.

In: Mayo Clinic Proceedings, Vol. 93, No. 4, 01.04.2018, p. 523-538.

Research output: Contribution to journalReview article

Hasan, TF, Rabinstein, A, Middlebrooks, EH, Haranhalli, N, Silliman, SL, Meschia, JF & Tawk, RG 2018, 'Diagnosis and Management of Acute Ischemic Stroke', Mayo Clinic Proceedings, vol. 93, no. 4, pp. 523-538. https://doi.org/10.1016/j.mayocp.2018.02.013
Hasan, Tasneem F. ; Rabinstein, Alejandro ; Middlebrooks, Erik H. ; Haranhalli, Neil ; Silliman, Scott L. ; Meschia, James F ; Tawk, Rabih G. / Diagnosis and Management of Acute Ischemic Stroke. In: Mayo Clinic Proceedings. 2018 ; Vol. 93, No. 4. pp. 523-538.
@article{cfe8f6178c4f47a9a1cccb61ab694c67,
title = "Diagnosis and Management of Acute Ischemic Stroke",
abstract = "Acute ischemic stroke (AIS) is among the leading causes of death and long-term disability. Intravenous tissue plasminogen activator has been the mainstay of acute therapy. Recently, several prospective randomized trials documented the value of endovascular revascularization in selected patients with large-vessel occlusion within the anterior circulation. This finding has led to a paradigm shift in the management of AIS, including wide adoption of noninvasive neuroimaging to assess vessel patency and tissue viability, with the supplemental and independent use of intravenous tissue plasminogen activator to improve clinical outcomes. In this article, we review the landmark studies on management of AIS and the current position on the diagnosis and management of AIS. The review also highlights the importance of early stabilization and prompt initiation of therapeutic interventions before, during, and after the diagnosis of AIS within and outside of the hospital.",
author = "Hasan, {Tasneem F.} and Alejandro Rabinstein and Middlebrooks, {Erik H.} and Neil Haranhalli and Silliman, {Scott L.} and Meschia, {James F} and Tawk, {Rabih G.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.mayocp.2018.02.013",
language = "English (US)",
volume = "93",
pages = "523--538",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "4",

}

TY - JOUR

T1 - Diagnosis and Management of Acute Ischemic Stroke

AU - Hasan, Tasneem F.

AU - Rabinstein, Alejandro

AU - Middlebrooks, Erik H.

AU - Haranhalli, Neil

AU - Silliman, Scott L.

AU - Meschia, James F

AU - Tawk, Rabih G.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Acute ischemic stroke (AIS) is among the leading causes of death and long-term disability. Intravenous tissue plasminogen activator has been the mainstay of acute therapy. Recently, several prospective randomized trials documented the value of endovascular revascularization in selected patients with large-vessel occlusion within the anterior circulation. This finding has led to a paradigm shift in the management of AIS, including wide adoption of noninvasive neuroimaging to assess vessel patency and tissue viability, with the supplemental and independent use of intravenous tissue plasminogen activator to improve clinical outcomes. In this article, we review the landmark studies on management of AIS and the current position on the diagnosis and management of AIS. The review also highlights the importance of early stabilization and prompt initiation of therapeutic interventions before, during, and after the diagnosis of AIS within and outside of the hospital.

AB - Acute ischemic stroke (AIS) is among the leading causes of death and long-term disability. Intravenous tissue plasminogen activator has been the mainstay of acute therapy. Recently, several prospective randomized trials documented the value of endovascular revascularization in selected patients with large-vessel occlusion within the anterior circulation. This finding has led to a paradigm shift in the management of AIS, including wide adoption of noninvasive neuroimaging to assess vessel patency and tissue viability, with the supplemental and independent use of intravenous tissue plasminogen activator to improve clinical outcomes. In this article, we review the landmark studies on management of AIS and the current position on the diagnosis and management of AIS. The review also highlights the importance of early stabilization and prompt initiation of therapeutic interventions before, during, and after the diagnosis of AIS within and outside of the hospital.

UR - http://www.scopus.com/inward/record.url?scp=85044162065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044162065&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2018.02.013

DO - 10.1016/j.mayocp.2018.02.013

M3 - Review article

VL - 93

SP - 523

EP - 538

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 4

ER -